Dr Dimitrios P. Kontoyiannis received his medical degree Summa Cum Laude from the National and Kapodistrian University of Athens in Greece. He then completed a postdoctoral clinical research fellowship in Mycology at the Section of Infectious Diseases at the University of Texas MD Anderson Cancer Center in Houston, Texas, followed by training in Internal Medicine at Baylor College of Medicine in Houston, where he served as a Chief Medical Resident. He was subsequently trained as a clinical fellow in Infectious Diseases at Massachusetts General Hospital and obtained a Master in Clinical Sciences from Harvard Medical School in Boston. He spent 3 years at the Whitehead Institute for Biomedical Sciences/Massachusetts Institute of Technology as a fellow in the Harvard MIT Clinical Investigators Training Program. He is currently the Director of the Mycology Research Program and Professor in the Department of Infectious Diseases Infection Control and Employee Health at the University of Texas MD Anderson Cancer Center. He is also an adjunct professor at the University of Houston College of Pharmacy. He serves as an associate editor for Medical Mycology and sits on the editorial boards of Antimicrobial Agents & Chemotherapy, Medical Mycology, and Transplant Infectious Disease. He is a reviewer in several peer-reviewed journals in infectious diseases, oncology, and hematology. Dr Kontoyiannis has authored more than 170 peer-reviewed manuscripts and over 30 invited articles and book chapters.
Dr Russell E. Lewis received his doctorate of pharmacy at the University of Kansas, followed by clinical residency training at Barnes-Jewish Hospital, Washington University Medical Center, in St. Louis, Missouri. He then pursued an infectious disease research fellowship focused in antifungal pharmacology in the colleges of Medicine and Pharmacy at the University of Iowa in Iowa City. From 1999 to 2011, he was on the faculty at the University of Houston College of Pharmacy and a clinical pharmacist and adjunct faculty member in the Department of Infectious Diseases at the University of Texas MD Anderson Cancer Center in Houston.
In 2011, Dr Lewis moved to Bologna, Italy, and was appointed Associate Professor in Infectious Diseases in the Department of Medical Sciences and Surgery at the University of Bologna. He also serves as a clinical pharmacologist for the Infectious Diseases Unit at S. Orsola-Malpighi Hospital in Bologna.
Dr Lewis has authored or co-authored over 200 papers and book chapters on the topics of antifungal pharmacology and infections in neutropenic cancer patients. He serves on the editorial board of Antimicrobial Agents and Chemotherapy and is a deputy editor for Mycoses. His research focuses on the pharmacology and immunological activity of antifungal agents. Recently his work has shifted to the development of clinical risk models to support diagnostic and treatment decisions for invasive fungal diseases and multidrug-resistant bacteria.